Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Albert C Ludolph; Joachim Schuster; Johannes Dorst; Luc Dupuis; Jens Dreyhaupt; Jochen H Weishaupt; Jan Kassubek; Ulrike Weiland; Susanne Petri; Thomas Meyer; Julian Grosskreutz; Berthold Schrank; Matthias Boentert; Alexander Emmer; Andreas Hermann; Daniel Zeller; Johannes Prudlo; Andrea S Winkler; Torsten Grehl; Michael T Heneka; Siw Wollebæk Johannesen; Bettina Göricke

doi:10.1016/S1474-4422(18)30176-5

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Albert C Ludolph
, Joachim Schuster
, Johannes Dorst
, Luc Dupuis
, Jens Dreyhaupt
, Jochen H Weishaupt
, Jan Kassubek
, Ulrike Weiland
, Susanne Petri
, Thomas Meyer
, Julian Grosskreutz
, Berthold Schrank
, Matthias Boentert
, Alexander Emmer
, Andreas Hermann
, Daniel Zeller
, Johannes Prudlo
, Andrea S Winkler
, Torsten Grehl
, Michael T Heneka

Siw Wollebæk Johannesen, Bettina Göricke

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

49 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	681-688
Fachzeitschrift	LANCET NEUROLOGY
Jahrgang	17
Ausgabenummer	8
DOIs	https://doi.org/10.1016/S1474-4422(18)30176-5
Publikationsstatus	Veröffentlicht - 2018

Zugriff auf Dokument

10.1016/S1474-4422(18)30176-5

Dieses zitieren

Ludolph, A. C., Schuster, J., Dorst, J., Dupuis, L., Dreyhaupt, J., Weishaupt, J. H., Kassubek, J., Weiland, U., Petri, S., Meyer, T., Grosskreutz, J., Schrank, B., Boentert, M., Emmer, A., Hermann, A., Zeller, D., Prudlo, J., Winkler, A. S., Grehl, T., ... Göricke, B. (2018). Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. LANCET NEUROLOGY, 17(8), 681-688. https://doi.org/10.1016/S1474-4422(18)30176-5

@article{cf82cb34ac0444649b2a1cd2cf780afa,

title = "Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.",

keywords = "DEXPRAMIPEXOLE, EMPOWER, DISEASE, MODEL, ALS",

author = "Ludolph, \{Albert C\} and Joachim Schuster and Johannes Dorst and Luc Dupuis and Jens Dreyhaupt and Weishaupt, \{Jochen H\} and Jan Kassubek and Ulrike Weiland and Susanne Petri and Thomas Meyer and Julian Grosskreutz and Berthold Schrank and Matthias Boentert and Alexander Emmer and Andreas Hermann and Daniel Zeller and Johannes Prudlo and Winkler, \{Andrea S\} and Torsten Grehl and Heneka, \{Michael T\} and \{Wolleb{\ae}k Johannesen\}, Siw and Bettina G{\"o}ricke",

note = "Bublitz: study group member: Department of Neurology, Technische Universit{\"a}t M{\"u}nchen",

year = "2018",

doi = "10.1016/S1474-4422(18)30176-5",

language = "English",

volume = "17",

pages = "681--688",

journal = "LANCET NEUROLOGY",

issn = "1474-4422",

publisher = "Elsevier ",

number = "8",

}

Ludolph, AC, Schuster, J, Dorst, J, Dupuis, L, Dreyhaupt, J, Weishaupt, JH, Kassubek, J, Weiland, U, Petri, S, Meyer, T, Grosskreutz, J, Schrank, B, Boentert, M, Emmer, A, Hermann, A, Zeller, D, Prudlo, J, Winkler, AS, Grehl, T, Heneka, MT, Wollebæk Johannesen, S & Göricke, B 2018, 'Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.', LANCET NEUROLOGY, Jg. 17, Nr. 8, S. 681-688. https://doi.org/10.1016/S1474-4422(18)30176-5

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. / Ludolph, Albert C; Schuster, Joachim; Dorst, Johannes et al.
in: LANCET NEUROLOGY, Jahrgang 17, Nr. 8, 2018, S. 681-688.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

AU - Ludolph, Albert C

AU - Schuster, Joachim

AU - Dorst, Johannes

AU - Dupuis, Luc

AU - Dreyhaupt, Jens

AU - Weishaupt, Jochen H

AU - Kassubek, Jan

AU - Weiland, Ulrike

AU - Petri, Susanne

AU - Meyer, Thomas

AU - Grosskreutz, Julian

AU - Schrank, Berthold

AU - Boentert, Matthias

AU - Emmer, Alexander

AU - Hermann, Andreas

AU - Zeller, Daniel

AU - Prudlo, Johannes

AU - Winkler, Andrea S

AU - Grehl, Torsten

AU - Heneka, Michael T

AU - Wollebæk Johannesen, Siw

AU - Göricke, Bettina

N1 - Bublitz: study group member: Department of Neurology, Technische Universität München

PY - 2018

Y1 - 2018

KW - DEXPRAMIPEXOLE

KW - EMPOWER

KW - DISEASE

KW - MODEL

KW - ALS

U2 - 10.1016/S1474-4422(18)30176-5

DO - 10.1016/S1474-4422(18)30176-5

M3 - Original Article

C2 - 29934198

SN - 1474-4422

VL - 17

SP - 681

EP - 688

JO - LANCET NEUROLOGY

JF - LANCET NEUROLOGY

IS - 8

ER -